Buy Canara Bank Ltd : Strong earnings beat; building of provisioning buffer positive - Emkay Global
Strong earnings beat; building of provisioning buffer positive
* Despite moderate credit growth and elevated provisions, Canara Bank reported a strong beat on PAT at Rs11.7bn (vs. est. Rs7bn), driven by strong margins, a one-off gain from the UB group stake sale and higher PSLC fees (seen across PSBs). Reported GNPA improved 43bps qoq to 8.5% due to contained slippages/higher upgrades.
* Restructured pool has doubled qoq to Rs183bn, 2.9% of loans, with a major contribution from retail, which is a bit concerning. The bank guides for FY22 slippages to be ~2.1-2.3% and expects higher recoveries from resolutions in some lumpy corporate accounts. CBK has identified NPAs to the tune of Rs51.5bn (0.8% of loans) to be transferred to NARCL.
* CBK has started building up a provision cover, which has been an irritant. Its specific PCR now stands at 61% and the Covid-related buffer at Rs13.4bn (0.2% of loans). However, CET 1 is sub-par at 8.9%, and thus the bank may consider raising capital soon.
* In our view, merger/asset quality related concerns are largely behind and the bank should report a gradual improvement in its RoA/RoE to 0.4-0.5%/10-11% by FY23E-24E (without factoring in dilution). Retain Buy with a revised TP of Rs185 (from Rs175), factoring in upgrades in earnings/multiple (core bank now valued at 0.6x vs. 0.5x).
Focus to shift to growth, and thus better LDR feeding into NIMs:
Credit growth was moderate at 5% yoy/1.5% qoq to Rs6.5trn, mainly due to corporate debulking and continued tepid growth in MSME (up 1.9% yoy/ down 1.3% qoq). The retail lending portfolio clocked 9.6% yoy growth, led by housing and vehicle portfolios. Deposit growth was strong at 12.3%yoy/1.1%qoq, leading to lower LDR. However, reported NIMs improved 21bps qoq to 2.7% due to better yields, lower CoF and interest reversal on NPAs. Given the asset quality stress largely behind, management has guided for a better growth trajectory. With CET 1 at a sub-par level of 8.9%, management has taken enabling resolution to raise capital via QIP.
Elevated stress, but building a provision buffer which otherwise has been an irritant: :
Headline asset quality has improved 43bps qoq, with GNPA ratio at 8.5% due to contained slippages and higher upgrades. Restructuring book stands at Rs183bn (Corporate- Rs43bn, MSME- Rs33bn and Retail and SBL- Rs96bn), 2.9% of loans. Specific non-technical PCR has inched up to 61% from low 40’s earlier, which is comforting. CBK has provided an additional Rs8.4bn during the quarter, resulting in a cumulative Covid-related buffer of Rs13.4bn (0.2% of advances). CBK expects both credit cost and slippages to be in the range of ~2.1-2.3% for FY22.
Outlook and valuations:
We believe that merger-related concerns are largely behind and the bank should report a gradual improvement in its RoA/RoE to 0.4-0.5%/10-11% by FY23E24E (without factoring in dilution), led by better growth and moderate LLP. Retain Buy with a revised TP of Rs185 (from Rs175), factoring in upgrades in earnings//multiple (core bank valued at 0.6x vs. 0.5x). Key risks to our call/estimates: Higher-than-expected NPA formation, a slower growth trajectory and a sharp rise in G-Sec yields leading to lower treasury gains.
To Read Complete Report & Disclaimer Click Here
For More Emkay Global Financial Services Ltd Disclaimer http://www.emkayglobal.com/Uploads/disclaimer.pdf & SEBI Registration number is INH000000354
Above views are of the author and not of the website kindly read disclaimer
Tag News
AU Small Finance Bank jumps on entering into bancassurance tie-ups with Star Health and Baja...
More News
Buy Mahindra and Mahindra Financial Services Ltd : Visibility improves on guided provisionin...